Compare EDSA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDSA | VERI |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 57.7M |
| IPO Year | 2018 | 2017 |
| Metric | EDSA | VERI |
|---|---|---|
| Price | $2.18 | $0.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $16.33 | $3.88 |
| AVG Volume (30 Days) | ★ 3.0M | 2.1M |
| Earning Date | 12-11-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $92,637,000.00 |
| Revenue This Year | N/A | $10.14 |
| Revenue Next Year | N/A | $26.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.30 |
| 52 Week High | $20.32 | $6.13 |
| Indicator | EDSA | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 30.22 |
| Support Level | $0.72 | N/A |
| Resistance Level | $4.10 | $0.67 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 15.27 | 19.06 |
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.